- Home
- XAIR vs HKPD Comparison
XAIR vs HKPD Comparison
Compare XAIR & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XAIR | HKPD |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5M | 10.6M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | XAIR | HKPD |
|---|---|---|
| Price | $1.35 | $0.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 142.5K |
| Earning Date | 11-10-2025 | 08-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $5,802,000.00 | ★ $20,313,818.00 |
| Revenue This Year | $261.11 | N/A |
| Revenue Next Year | $151.82 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 147.74 | 21.72 |
| 52 Week Low | $1.19 | $0.81 |
| 52 Week High | $11.56 | $3.79 |
Technical Indicators
Market Signals| Indicator | XAIR | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 30.99 | 35.84 |
| Support Level | $1.19 | $0.92 |
| Resistance Level | $1.38 | $1.11 |
| Average True Range (ATR) | 0.11 | 0.13 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 20.15 | 12.91 |
Price Performance
Historical ComparisonAbout XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.